MedPath

Effect of using Cloxacillin as an Antibiotic Lock Solution versus placebo on prevention of catheter-associated infection in hemodialysis patients

Phase 3
Recruiting
Conditions
Catheter-associated infection.
Infection due to central venous catheter
T80.21
Registration Number
IRCT20120215009014N272
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
124
Inclusion Criteria

Age of 18 to 80 years
Hemodialysis

Exclusion Criteria

Using immunosuppressive drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessing the catheter-associated infection. Timepoint: Every week for 4 weeks. Method of measurement: Through physical examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath